WntResearch Investor Relations Material
Latest events
Q3 2022
WntResearch
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from WntResearch
Access all reports
WntResearch is a biotechnology company specializing in oncology, focusing on the development of therapies aimed at preventing the spread of cancer. The company's approach involves targeting the metastatic process by researching the endogenous protein WNT5A, which plays a critical role in the mobility and spread of tumor cells within the body. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇸🇪 Sweden